Clinical Trial Update: Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease [Phase 3]

View source ↗

Summary

A multi-centre UK Phase 3 trial of donepezil in early dementia associated with Parkinson's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinson Disease with Dementia

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust | Conditions: Parkinson's Disease | Phase 3 | Status: TERMINATED